XCR1+ type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis-Reference-Cited by-同舟云学术

XCR1+ type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis

Published:2021-05-20 Issue:6 Volume:27 Page:1043-1054
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Deczkowska Aleksandra^ORCID,David Eyal,Ramadori Pierluigi,Pfister Dominik,Safran Michal,Li Baoguo,Giladi Amir,Jaitin Diego Adhemar,Barboy Oren,Cohen Merav,Yofe Ido,Gur Chamutal,Shlomi-Loubaton Shir,Henri Sandrine^ORCID,Suhail Yousuf,Qiu Mengjie,Kam Shing,Hermon Hila,Lahat Eylon,Ben Yakov Gil,Cohen-Ezra Oranit,Davidov Yana,Likhter Mariya,Goitein David,Roth Susanne,Weber Achim^ORCID,Malissen Bernard^ORCID,Weiner Assaf,Ben-Ari Ziv,Heikenwälder Mathias^ORCID,Elinav Eran^ORCID,Amit Ido^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

https://www.nature.com/articles/s41591-021-01344-3.pdf

Reference67 articles.

1. Brunt, E. M. et al. Nonalcoholic fatty liver disease. Nat. Rev. Dis. Prim. 1, 15080 (2015).

2. Diehl, A. M. & Day, C. Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis. N. Engl. J. Med. 377, 2063–2072 (2017).

3. Anstee, Q. M., Reeves, H. L., Kotsiliti, E., Govaere, O. & Heikenwälder, M. From NASH to HCC: current concepts and future challenges. Nat. Rev. Gastroenterol. Hepatol. 16, 411–428 (2019).

4. Friedman, S. L., Neuschwander-Tetri, B. A., Rinella, M. & Sanyal, A. J. Mechanisms of NAFLD development and therapeutic strategies. Nat. Med. 24, 908–922 (2018).

5. Chalasani, N. et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology 67, 328–357 (2018).

Cited by 117 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The immune microenvironment of steatotic hepatocellular carcinoma: Current findings and future prospects;Hepatology Communications;2024-09

2. Integrins and NAFLD-associated liver diseases: clinical associations, pathophysiological mechanisms and pharmacological implications;Acta Biochimica et Biophysica Sinica;2024-09-01

3. Role of gut microbiota and immune cells in metabolic-associated fatty liver disease: clinical impact;Hepatology International;2024-07-12

4. The Role of CD4+T Cells in Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma;International Journal of Molecular Sciences;2024-06-23

5. The role relationship played by immune cells and circulating inflammatory proteins in NAFLD;2024-05-31